Open AccessImpact of Procedural Bleeding in Peripheral Artery Disease
Author(s) -
Aman Kansal,
Zhen Huang,
Frank W. Rockhold,
Iris Baumgärtner,
Jeffrey S. Berger,
Juuso Blomster,
F. Gerry R. Fowkes,
Brian G. Katona,
Kenneth W. Mahaffey,
Lars Norgren,
William R. Hiatt,
Manesh R. Patel,
W. Schuyler Jones
Publication year - 2019
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.119.008069
Subject(s) - medicine , myocardial infarction , revascularization , thrombolysis , cardiology , coronary artery disease , surgery , clinical endpoint , vascular disease , clopidogrel , amputation , stroke (engine) , randomized controlled trial , mechanical engineering , engineering
The incidence of Thrombolysis in Myocardial Infarction major/minor bleeding following peripheral revascularization is comparable to rates after coronary revascularization and lower extremity amputation, and the majority of bleeding events occur within 7 days following the procedure. The severity of periprocedural bleeding is also similar after procedures, with the most frequently adjudicated reason being a drop in hemoglobin ≥2 g/dL. Future studies should be performed to enhance our understanding of bleeding risk related to revascularization and amputation procedures in peripheral artery disease patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom